Enhanced TLR7-induced interferon responses in women living with HIV

Introduction: Biological sex is a key modifier of HIV pathogenesis, with women more frequently achieving spontaneous viral control than men. Toll-like receptor 7 (TLR7), an endosomal RNA sensor encoded on the X chromosome that escapes X-inactivation, plays a pivotal role in antiviral immunity and is increasingly targeted in HIV cure strategies aimed at reversing viral latency. However, it remains unclear whether TLR7-driven immune responses differ by sex in the context of HIV infection. Methods: We characterized sex-specific immune responses to TLR7 stimulation in a cohort of 1,326 antiretroviral therapy (ART)-suppressed individuals living with HIV (192 women, 1,134 men), including 50 spontaneous HIV controllers, and in 43 people living without HIV (28 women, 15 men). Peripheral blood mononuclear cells (PBMCs) were stimulated ex vivo with the TLR7 agonist imiquimod (IMQ), followed by cytokine profiling and transcriptome analysis by RNA sequencing. To investigate transcriptional priming at baseline, we additionally analyzed single-cell RNA-sequencing (scRNA-seq) data from unstimulated PBMCs of 76 women and 214 men living with HIV. Results: PBMCs of women living with HIV (WLWH) released significantly lower amounts of IL-1β and MIP-1α (p < 0.01) following IMQ stimulation than PBMCs of men living with HIV (MLWH), with trends toward reduced IL-8 and IL-1Ra (p < 0.06), while IL-6 and MCP-1 production was similar across sexes. Transcriptomic analysis revealed sex-dependent gene programs following TLR7 activation. Women living without HIV (WLWoH) showed selectively higher IFNγ (type II interferon) signaling and downregulated B cell-associated transcripts compared to men living without HIV (MLWoH). In contrast, WLWH exhibited a pronounced induction of both IFNα (type I) and IFNγ (type II) pathways, marked by elevated expression of interferon-stimulated genes including IRF7, ISG15, MX1, and APOBEC3A, alongside reduced antibacterial and inflammatory signatures compared to MLWH. Single-cell RNA sequencing further identified IRF7 as a key ISG selectively upregulated in plasmacytoid dendritic cells (pDCs) of WLWH. These transcriptional responses were independent of pDC frequency and did not differ between HIV controllers and non-controllers. Discussion: Despite the male-biased cohort, these findings demonstrate that women mount stronger interferon-driven responses upon TLR7 activation compared to men, accompanied by attenuated inflammatory cytokine production. These sex-based immunological differences may contribute to improved viral control in women and highlight the importance of incorporating sex as a biological variable in TLR7-targeted HIV immunotherapies.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-04-21
DOI
https://doi.org/10.3389/fimmu.2026.1791579
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Enhanced TLR7-induced interferon responses in women living with HIV

Vasiliki Matzaraki, A J van der Ven, Suzanne D. E. Ruijten, Anna C. Aschenbrenner et al.
Frontiers in Immunology
HIV Research and Treatment
article

Enhanced TLR7-induced interferon responses in women living with HIV

Vasiliki Matzaraki, A J van der Ven, Suzanne D. E. Ruijten, Anna C. Aschenbrenner, Nadira Vadaq, Victoria Rios-Vazquez, Wilhelm A. J. W. Vos, Alisa Huber, Joachim L. Schultze, Joost A.H. Martens, Louise E. van Eekeren, Marc J.T. Blaauw, Leo A.B. Joosten, Jéssica C. dos Santos, Adriana Navas, Albert L. Groenendijk, Jan van Lunzen, Rainer Knoll, Maartje C.P. Jacobs-Cleophas, Mihai G. Netea
article en

Abstract

Introduction: Biological sex is a key modifier of HIV pathogenesis, with women more frequently achieving spontaneous viral control than men. Toll-like receptor 7 (TLR7), an endosomal RNA sensor encoded on the X chromosome that escapes X-inactivation, plays a pivotal role in antiviral immunity and is increasingly targeted in HIV cure strategies aimed at reversing viral latency. However, it remains unclear whether TLR7-driven immune responses differ by sex in the context of HIV infection. Methods: We characterized sex-specific immune responses to TLR7 stimulation in a cohort of 1,326 antiretroviral therapy (ART)-suppressed individuals living with HIV (192 women, 1,134 men), including 50 spontaneous HIV controllers, and in 43 people living without HIV (28 women, 15 men). Peripheral blood mononuclear cells (PBMCs) were stimulated ex vivo with the TLR7 agonist imiquimod (IMQ), followed by cytokine profiling and transcriptome analysis by RNA sequencing. To investigate transcriptional priming at baseline, we additionally analyzed single-cell RNA-sequencing (scRNA-seq) data from unstimulated PBMCs of 76 women and 214 men living with HIV. Results: PBMCs of women living with HIV (WLWH) released significantly lower amounts of IL-1β and MIP-1α (p < 0.01) following IMQ stimulation than PBMCs of men living with HIV (MLWH), with trends toward reduced IL-8 and IL-1Ra (p < 0.06), while IL-6 and MCP-1 production was similar across sexes. Transcriptomic analysis revealed sex-dependent gene programs following TLR7 activation. Women living without HIV (WLWoH) showed selectively higher IFNγ (type II interferon) signaling and downregulated B cell-associated transcripts compared to men living without HIV (MLWoH). In contrast, WLWH exhibited a pronounced induction of both IFNα (type I) and IFNγ (type II) pathways, marked by elevated expression of interferon-stimulated genes including IRF7, ISG15, MX1, and APOBEC3A, alongside reduced antibacterial and inflammatory signatures compared to MLWH. Single-cell RNA sequencing further identified IRF7 as a key ISG selectively upregulated in plasmacytoid dendritic cells (pDCs) of WLWH. These transcriptional responses were independent of pDC frequency and did not differ between HIV controllers and non-controllers. Discussion: Despite the male-biased cohort, these findings demonstrate that women mount stronger interferon-driven responses upon TLR7 activation compared to men, accompanied by attenuated inflammatory cytokine production. These sex-based immunological differences may contribute to improved viral control in women and highlight the importance of incorporating sex as a biological variable in TLR7-targeted HIV immunotherapies.

Frontiers in ImmunologyVol. 17
Radboud University Nijmegen (NL), Iuliu Hațieganu University of Medicine and Pharmacy (RO), German Center for Neurodegenerative Diseases (DE), Erasmus MC (NL), Radboud University Medical Center (NL), Radboud Institute for Molecular Life Sciences (NL), Office of Infectious Diseases (US), Elisabeth-TweeSteden Ziekenhuis (NL), Life & Brain (Germany) (DE), Erasmus University Rotterdam (NL)
ViiV Healthcare, Radboud Universitair Medisch Centrum
Good health and well-being
Openalex Percentile: Top 17%
HIV Research and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.